TABLE 2 

Viruses identified by two methods of high-throughput sequencing on plasma samples from Tanzanian patients with febrile illness

SampleUnbiased HTSaVirCapSeq-VERTConfirmation
(PCR result)
Total no.
of readsb
Virus(es)
identifiedc
No. of
viral reads
Genome
coverage
(%)
Terminal
NCR
coverage
(%)d
Total no. of
reads
Virus(es)
identified
No. of
viral reads
Genome
coverage
(%)
Terminal
NCR
coverage
(%)
Sample 1303,201,174DV21,032,12810010058,001,148DV254,739,61899.999.4Positive
Sample 2191,759,852DV2616,2911001004,359,471DV21,663,51699.998.0Positive
HPgV27,95395.8100HPgV33,50589.273.6Positive
Sample 3240,702,142WNV48384.955.82,186,326WNV52969.60.0Positive
Sample 4233,216,250WNV4817.226.61,413,970WNV456.50.0Positive
Sample 5156,590,622HIV-133,02886.968.462,168,103HIV-157,677,44397.299.8Positive
Sample 6317,810,172ND2,646,613ND
Sample 7187,583,832HIV-113839.20.02,171,536HIV-14,58680.749.0Positive
EBV450.20.0EBV450.90.0Positive
HPgV26351.636.1HPgV2,93559.769.6Positive
Sample 8199,784,946ND2,601,036EBV30.040.0Positive
Sample 9206,125,028DV27,73699.895.92,807,056DV2538,38799.998.0Positive
Sample 10391,029,362ND2,056,237ND
Sample 11214,938,600ND1,958,631ND
Sample 12127,295,376DV25,144,2231001008,104,818DV25,355,68499.998.2Positive
  • a HTS, high-throughput sequencing.

  • b The total number of reads is shown in boldface type for emphasis.

  • c DV2, dengue virus 2; HPgV, human pegivirus; WBV, West Nile virus; ND, no virus detected; EBV, Epstein-Barr virus.

  • d NCR, noncoding region.